BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38394385)

  • 21. Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia.
    Getachew S; Getachew E; Gizaw M; Ayele W; Addissie A; Kantelhardt EJ
    PLoS One; 2019; 14(5):e0216522. PubMed ID: 31075122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Ngwibete A; Ogunbode O; Swende LT; Agbada MM; Omigbodun A
    Pan Afr Med J; 2024; 47():50. PubMed ID: 38681110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 24. Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
    Lott BE; Halkiyo A; Kassa DW; Kebede T; Dedefo A; Ehiri J; Madhivanan P; Carvajal S; Soliman A
    BMC Womens Health; 2021 May; 21(1):185. PubMed ID: 33941159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast and cervical cancer patients' experience in Addis Ababa city, Ethiopia: a follow-up study protocol.
    Gebremariam A; Addissie A; Worku A; Hirpa S; Assefa M; Pace LE; Kantelhardt EJ; Jemal A
    BMJ Open; 2019 Apr; 9(4):e027034. PubMed ID: 30967409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precancerous cervical lesion screening acceptance among women in Eastern Ethiopia.
    Wakwoya EB; Sadi CG; Sendo EG
    BMJ Open; 2023 Nov; 13(11):e073721. PubMed ID: 37931971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    Kaizilege GK; Ndaboine E; Chuma C; Mujuni F; Kiritta R; Matovelo D; Ottoman O; Elias E; Masalu N; Kidenya BR; Mazigo HD
    BMC Cancer; 2024 Jan; 24(1):66. PubMed ID: 38216912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
    BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
    Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S
    Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
    Derbie A; Amare B; Misgan E; Nibret E; Maier M; Woldeamanuel Y; Abebe T
    PLoS One; 2022; 17(9):e0274466. PubMed ID: 36094938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program.
    Vidhubala E; Niraimathi K; Shewade HD; Mahadevan S
    J Epidemiol Glob Health; 2020 Mar; 10(1):28-35. PubMed ID: 32175707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
    Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
    BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV-positive women attending public health centers in Addis Ababa city, Ethiopia.
    Shiferaw S; Addissie A; Gizaw M; Hirpa S; Ayele W; Getachew S; Kantelhardt EJ; Assefa M; Jemal A
    Cancer Med; 2018 Mar; 7(3):903-912. PubMed ID: 29441700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
    Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women.
    Duggan C; Coronado G; Martinez J; Byrd TL; Carosso E; Lopez C; Benavides M; Thompson B
    BMC Cancer; 2012 May; 12():170. PubMed ID: 22559251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
    Tsegaye K; Hagos A; Kindie H; Minyihun A; Teshale G
    BMC Cancer; 2023 Oct; 23(1):1034. PubMed ID: 37880629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.